These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 26381230)

  • 1. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the gut microbiome to combat neurodegeneration.
    Sasmita AO
    Rev Neurosci; 2019 Nov; 30(8):795-805. PubMed ID: 31095511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota in ALS: possible role in pathogenesis?
    McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
    Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
    [No Abstract]   [Full Text] [Related]  

  • 4. [A role of the gastrointestinal tract microbiota in the pathogenesis of Parkinson's disease].
    Alifirova VM; Zhukova NG; Zhukova IA; Latypova AV; Titova MA; Mironova YS; Izhboldina OP; Nikitina MA; Petrov VA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):174-179. PubMed ID: 28635757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
    Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
    BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.
    Fang X
    Metab Brain Dis; 2018 Aug; 33(4):1031-1043. PubMed ID: 29681010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.
    Felice VD; Quigley EM; Sullivan AM; O'Keeffe GW; O'Mahony SM
    Parkinsonism Relat Disord; 2016 Jun; 27():1-8. PubMed ID: 27013171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
    J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
    Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
    Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking Smoking, Coffee, Urate, and Parkinson's Disease - A Role for Gut Microbiota?
    Scheperjans F; Pekkonen E; Kaakkola S; Auvinen P
    J Parkinsons Dis; 2015; 5(2):255-62. PubMed ID: 25882059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fecal microbiome of ALS patients.
    Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
    Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Microbiome as a Modifier of Neurodegenerative Disease Risk.
    Fang P; Kazmi SA; Jameson KG; Hsiao EY
    Cell Host Microbe; 2020 Aug; 28(2):201-222. PubMed ID: 32791113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle.
    Scheperjans F
    Curr Opin Neurol; 2016 Dec; 29(6):773-780. PubMed ID: 27653288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the gut microbiota in the development of various neurological diseases.
    Castillo-Álvarez F; Marzo-Sola ME
    Neurologia (Engl Ed); 2022; 37(6):492-498. PubMed ID: 35779869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the gut microbiota in the development of various neurological diseases.
    Castillo-Álvarez F; Marzo-Sola ME
    Neurologia (Engl Ed); 2022; 37(6):492-498. PubMed ID: 31340904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
    Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
    Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.